Ultrasound-guided Thoracic Spinal Level Identification

Sponsor
Seoul National University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04223700
Collaborator
(none)
100
1
23.1

Study Details

Study Description

Brief Summary

Typically, the rhomboid minor muscles rise from the C7-T1 spinous process and run downward to touch the upper inner corner of the scapula, and the rhomboid major muscles rise from the T2-T5 spinous process and run downward to reach the lower middle inner corner of the scapula. In anatomical research articles, it has been reported that the rhomboid muscle's anatomical variations are rare. Considering the characteristics of these rhomboid muscles, the investigators planned a study on the utility of rhomboid muscles as a landmark for identifying thoracic spine levels.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ultrasound imaging & fluoroscopic confirmation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Ultrasound-guided Thoracic Spinal Level Identification Using Rhomboid Muscle as a Reference Landmark
Anticipated Study Start Date :
Jan 13, 2020
Anticipated Primary Completion Date :
Dec 15, 2021
Anticipated Study Completion Date :
Dec 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1

Ultrasound scanning of the rhomboid muscle

Procedure: Ultrasound imaging & fluoroscopic confirmation
The researchers use ultrasound to scan the left and right sides of the paravertebral sagittal imaging to identify trapezius, semispinalis, erector spinae muscle, transverse process and rhomboid muscle. The radiopaque marker is attached respectively to the skin of the inferior margin of the rhomboid muscle on the left and right thoracic spinal spines. Then, as the first step for the scheduled nerve block to the patient, thoracic vertebra level verification using C-arm is performed. At this time, left and right level of the transverse process of thoracic spine marked with the radiopaque marker are confirmed and recorded.

Outcome Measures

Primary Outcome Measures

  1. Ultrasound-guided Thoracic Spinal Level [during the procedure]

    Thoracic vertebra level of radiopaque marker labeled on the rhomboid muscle inferior margin on C-arm

Secondary Outcome Measures

  1. 1. Changes in marker position when raised the arm above the head and in a relaxed position [during the procedure]

  2. 2. Rhomboid muscle variation [during the procedure]

    The presence of rhomboid muscle fusion

  3. 3. Visibility grade of muscle fascia using Ultrasound (I - IV) [during the procedure]

    A. Grade I: Definitely visible B. Grade II: Somewhat visible C. Grade III: Barely visible D. Grade IV: Not visible

  4. 4. Depth: The distance from the skin where the marker is attached to the transverse process of thoracic spine [during the procedure]

  5. 5. Difference between left and right sides [during the procedure]

    The distance between left and right inferior thoracic spine attachment site of rhomboid muscle

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing thoracic nerve root block due to herpes zoster, postherpetic neuralgia, complex regional pain syndrome, post traumatic pain syndrome, or compression fracture of vertebra.
Exclusion Criteria:
  1. Previous T-spine surgery

  2. Patient refusal

  3. Coagulopathy

  4. Generalized infection or localized infection at injection site

  5. Anatomical abnormality of T-spine

  6. Allergic reaction to local anesthetics

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Seoul National University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeeyoun Moon, Associate Professor, Seoul National University
ClinicalTrials.gov Identifier:
NCT04223700
Other Study ID Numbers:
  • 1911-063-1078
First Posted:
Jan 10, 2020
Last Update Posted:
Jan 10, 2020
Last Verified:
Jan 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Jeeyoun Moon, Associate Professor, Seoul National University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2020